Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 1,126.50
+11.00 (0.99%)
At close: Jul 31, 2026
Zydus Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,123,987 | 876,631 | 891,926 | 1,013,630 | 497,549 | 356,774 | |
Market Cap Growth | 12.25% | -1.71% | -12.01% | 103.72% | 39.46% | -20.96% |
Enterprise Value | 1,224,130 | 930,186 | 892,181 | 1,022,435 | 525,557 | 387,118 |
Last Close Price | 1126.50 | 870.42 | 874.88 | 990.50 | 479.82 | 337.99 |
PE Ratio | 22.30 | 17.39 | 19.71 | 26.26 | 25.38 | 7.95 |
PS Ratio | 4.14 | 3.23 | 3.84 | 5.19 | 2.89 | 2.36 |
PB Ratio | 3.80 | 2.96 | 3.38 | 4.59 | 2.53 | 1.87 |
P/TBV Ratio | 11.58 | 9.03 | 5.76 | 8.48 | 4.28 | 3.40 |
P/FCF Ratio | - | - | 17.53 | 44.27 | 30.01 | 39.56 |
P/OCF Ratio | 53.10 | 41.42 | 13.15 | 31.71 | 18.50 | 16.95 |
EV/Sales Ratio | 4.51 | 3.43 | 3.84 | 5.23 | 3.05 | 2.56 |
EV/EBITDA Ratio | 16.79 | 12.98 | 13.06 | 19.45 | 14.87 | 12.21 |
EV/EBIT Ratio | 20.67 | 15.97 | 14.97 | 22.53 | 18.42 | 15.65 |
EV/FCF Ratio | - | - | 17.54 | 44.65 | 31.70 | 42.92 |
Debt / Equity Ratio | 0.42 | 0.42 | 0.12 | 0.04 | 0.06 | 0.22 |
Debt / EBITDA Ratio | 1.74 | 1.74 | 0.47 | 0.16 | 0.34 | 1.33 |
Debt / FCF Ratio | - | - | 0.63 | 0.36 | 0.72 | 4.68 |
Net Debt / Equity Ratio | 0.26 | 0.26 | -0.09 | -0.02 | 0 | 0.01 |
Net Debt / EBITDA Ratio | 1.05 | 1.05 | -0.35 | -0.10 | 0.00 | 0.08 |
Net Debt / FCF Ratio | -5.90 | -5.90 | -0.48 | -0.23 | 0.00 | 0.27 |
Asset Turnover | 0.61 | 0.61 | 0.70 | 0.71 | 0.64 | 0.59 |
Inventory Turnover | 1.57 | 1.57 | 1.77 | 1.87 | 1.81 | 1.64 |
Quick Ratio | 0.67 | 0.67 | 1.13 | 1.30 | 1.05 | 0.96 |
Current Ratio | 1.27 | 1.27 | 1.89 | 2.14 | 1.81 | 1.54 |
Return on Equity (ROE) | 18.32% | 18.32% | 19.28% | 18.90% | 10.82% | 13.96% |
Return on Assets (ROA) | 8.13% | 8.13% | 11.21% | 10.31% | 6.66% | 5.98% |
Return on Invested Capital (ROIC) | 13.11% | 14.55% | 20.12% | 17.64% | 11.43% | 10.78% |
Return on Capital Employed (ROCE) | 15.90% | 15.90% | 21.20% | 19.00% | 14.10% | 12.40% |
Earnings Yield | 4.48% | 5.75% | 5.07% | 3.81% | 3.94% | 12.58% |
FCF Yield | -1.14% | -1.46% | 5.70% | 2.26% | 3.33% | 2.53% |
Dividend Yield | 0.09% | 0.11% | 1.26% | 0.30% | 1.25% | 0.74% |
Payout Ratio | 21.95% | 21.95% | 6.68% | 16.09% | 13.63% | 8.29% |
Buyback Yield / Dilution | - | - | 0.56% | 0.37% | 0.79% | - |
Total Shareholder Return | 0.09% | 0.11% | 1.82% | 0.67% | 2.04% | 0.74% |